| 1 |
Radiotherapy-induced metabolic hallmarks in the tumor microenvironment |
|
|
| Anjali Mittal, Minal Nenwani, Itisam Sarangi, Abhinav Achreja, Theodore S. Lawrence, Deepak Nagrath |
|
| Trends in Cancer. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy |
|
|
| Mattia Zaffaroni, Maria Giulia Vincini, Giulia Corrao, Giulia Marvaso, Matteo Pepa, Giuseppe Viglietto, Nicola Amodio, Barbara Alicja Jereczek-Fossa |
|
| International Journal of Molecular Sciences. 2022; 23(19): 11343 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Assessment of Radiation Resistance and Therapeutic Targeting of Cancer Stem Cells: A Raman Spectroscopic Study of Glioblastoma |
|
|
| Srividya Kumar, Abhirami Visvanathan, Arimappamagan Arivazhagan, Vani Santhosh, Kumaravel Somasundaram, Siva Umapathy |
|
| Analytical Chemistry. 2018; 90(20): 12067 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
High glycolytic activity of tumor cells leads to underestimation of electron transport system capacity when mitochondrial ATP synthase is inhibited |
|
|
| Juliana S. Ruas, Edilene S. Siqueira-Santos, Erika Rodrigues-Silva, Roger F. Castilho |
|
| Scientific Reports. 2018; 8(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine |
|
|
| Lili Guo, Alexander A. Shestov, Andrew J. Worth, Kavindra Nath, David S. Nelson, Dennis B. Leeper, Jerry D. Glickson, Ian A. Blair |
|
| Journal of Biological Chemistry. 2016; 291(1): 42 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond? |
|
|
| Lynn Jeanette Savic, Julius Chapiro, Gregor Duwe, Jean-François Geschwind |
|
| Hepatic Oncology. 2016; 3(1): 19 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer |
|
|
| Jermaine Coward,Angus Harding |
|
| Frontiers in Oncology. 2014; 4 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors |
|
|
| Prudence Donovan,Kathleen Cato,Roxane Legaie,Rumal Jayalath,Gemma Olsson,Bruce Hall,Sarah Olson,Samuel Boros,Brent A. Reynolds,Angus Harding |
|
| Molecular BioSystems. 2014; 10(4): 741 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Is Cancer a Metabolic Disease? |
|
|
| Hilary A. Coller |
|
| The American Journal of Pathology. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by 2-Deoxy-D-Glucose in Combination Therapy |
|
|
| Fahimeh Aghaee,Jalil Pirayesh Islamian,Behzaad Baradaran |
|
| Journal of Breast Cancer. 2012; 15(2): 141 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy |
|
|
| Tineke W.H. Meijer, Johannes H.A.M. Kaanders, Paul N. Span, Johan Bussink |
|
| Clinical Cancer Research. 2012; 18(20): 5585 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Non-cytotoxic radiosensitizers in brain radiotherapy: Journey till the first decade of this millennium |
|
|
| Mohindra, P., Sinha, R.N., Andrews, R.J., Khuntia, D. |
|
| Current Cancer Drug Targets. 2012; 12(3): 260-278 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response |
|
|
| Richardson, E., Stockwell, S.R., Li, H., Aherne, W., Cuomo, M.E., Mittnacht, S. |
|
| PLoS ONE. 2012; 7(2): art-e31627 |
|
| [Pubmed] [Google Scholar] |
|
